Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Wenming Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0691-8333; OpenAlex author ID A5101755677. Sources: OpenAlex.

Their work

Papers
23 (first author 0, last author 11)
Trials
0
Grants
0
Labs led
1
Collaborators
62
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 2 papers · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: 3 papers · 2020: 1 paper · 2021: 3 papers · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers · 2025: 2 papers · 2026: 5 papers

Papers 23

  1. Tumor-educated adipocytes promote muscle wasting via EV-packaged miR-221-3p targeting IRS1 in pancreatic cancer cachexia. Last author DOI 10.1016/j.canlet.2026.218795↗
  2. Bioengineering advances in pancreatic cancer organoids for reproducible tumor microenvironment modeling. Last author DOI 10.1016/j.isci.2026.116487↗
  3. Drug-associated pancreatic cancer: insights from real-world pharmacovigilance and network pharmacology. Last author DOI 10.1080/14740338.2025.2469273↗
  4. Neutrophil extracellular traps induced by tumour-derived NGAL reprogram CAF subtypes via ITGA5 to promote tumour progression in pancreatic cancer. Co-author DOI 10.1136/gutjnl-2025-337720↗
  5. Clinical quality of large language model answers to questions about pancreatic cancer Last author DOI 10.21203/rs.3.rs-10624412/v1↗
  6. Pancreatic cancer cachexia: A systemic consequence of multi-organ interactions. Last author DOI 10.1016/j.hlife.2025.05.002↗
  7. Oncogenic KRAS Promotes Ferroptosis in Pancreatic Cancer Through Regulation of the Fosl1-Tfrc Axis. Last author DOI 10.1097/mpa.0000000000002426↗
  8. Gut resistome profiling reveals high diversity and fluctuations in pancreatic cancer cohorts. Last author DOI 10.3389/fcimb.2024.1354234↗
  9. Role and functional mechanisms of IL‑17/IL‑17R signaling in pancreatic cancer (Review). Last author DOI 10.3892/or.2024.8803↗
  10. Prognostic value of preoperative [68 Ga]Ga-FAPI-04 PET/CT in patients with resectable pancreatic ductal adenocarcinoma in correlation with immunohistological c… Co-author DOI 10.1007/s00259-022-06100-4↗
  11. Early Detection of Pancreatic Cancer: Are We Ready for Prime Time? Co-author DOI 10.1053/j.gastro.2022.07.072↗
  12. Comparison of minimal invasive versus open radical antegrade modular pancreatosplenectomy (RAMPS) for pancreatic ductal adenocarcinoma: a single center retrosp… Co-author DOI 10.1007/s00464-020-07938-1↗
  13. Interleukin-17 activates and synergizes with the notch signaling pathway in the progression of pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.canlet.2021.03.003↗
  14. Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate pancreatic cancer. Co-author DOI 10.1038/s43018-020-00134-z↗
  15. Combined blockade of TGf-β1 and GM-CSF improves chemotherapeutic effects for pancreatic cancer by modulating tumor microenvironment. Co-author DOI 10.1007/s00262-020-02542-7↗
  16. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41422-019-0195-y↗
  17. Author Correction: Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41422-019-0212-1↗
  18. [The effect of para-aortic lymph node metastasis on the resectability of pancreatic cancer]. Co-author DOI 10.3760/cma.j.issn.0529-5815.2019.01.014↗
  19. Advances in understanding the molecular mechanism of pancreatic cancer metastasis. Co-author DOI 10.1016/s1499-3872(15)60033-9↗
  20. Catechol-O-methyltransferase, a new target for pancreatic cancer therapy. Co-author DOI 10.1111/cas.12648↗
  21. The prognostic value of Cyclin B1 in pancreatic cancer. Co-author DOI 10.1007/s12032-014-0107-4↗
  22. Prognostic significance of epidermal growth factor-like domain 7 in pancreatic cancer. Co-author DOI 10.1016/s1499-3872(14)60272-1↗
  23. Increased COMT expression in pancreatic cancer and correlation with clinicopathologic parameters. Co-author DOI 10.1007/s11427-012-4375-y↗

Closest collaborators

The 25 strongest of 62 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yupei Zhao · 9 shared papers, 2012–2026 · strength 0.95
  2. Aoyi Xiao · 3 shared papers, 2025–2026 · strength 0.78
  3. Xudong Liu · 3 shared papers, 2024–2026 · strength 0.76
  4. Xianze Wang · 3 shared papers, 2021–2026 · strength 0.72
  5. Junya Peng · 5 shared papers, 2019–2026 · strength 0.71
  6. Renyu Chen · 2 shared papers, 2026 · strength 0.61
  7. Wenze Wang · 5 shared papers, 2015–2026 · strength 0.58
  8. Xianlin Han · 2 shared papers, 2026 · strength 0.55
  9. Taiping Zhang · 6 shared papers, 2014–2023 · strength 0.53
  10. Qiang Xu · 1 shared paper, 2026 · strength 0.43
  11. Hao Xie · 1 shared paper, 2026 · strength 0.43
  12. Huanwen Wu · 3 shared papers, 2015–2026 · strength 0.40
  13. Huijia Zhao · 1 shared paper, 2025 · strength 0.37
  14. Wanli Liu · 1 shared paper, 2024 · strength 0.36
  15. Junchao Guo · 5 shared papers, 2014–2021 · strength 0.36
  16. Menghua Dai · 4 shared papers, 2019–2021 · strength 0.35
  17. Ruohan Cui · 1 shared paper, 2026 · strength 0.29
  18. Hongmei Dai · 3 shared papers, 2015–2021 · strength 0.29
  19. Quan Liao · 3 shared papers, 2019–2021 · strength 0.28
  20. Jingcheng Zhang · 1 shared paper, 2025 · strength 0.27
  21. Wanli Liu · 1 shared paper, 2026 · strength 0.26
  22. Li Zhou · 5 shared papers, 2012–2020 · strength 0.25
  23. W.T. Liu · 1 shared paper, 2026 · strength 0.25
  24. Mingyang Liu · 1 shared paper, 2026 · strength 0.25
  25. Lei You · 5 shared papers, 2012–2016 · strength 0.25

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.